88.65
-0.48%
Close of 16 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Price performance
Chart by TradingView, with its own licensed prices
- Market value
- $15.35bn
- Last close × shares
- Volume
- 848.1k
- Shares, 16 Nov 2026
- Price to earnings
- 10.0
About Solventum
From its filings with the US Securities and Exchange Commission
Solventum is based in Eagan, Minnesota and is incorporated in Delaware. Its shares trade on NYSE under the ticker SOLV. It is a member of the S&P 500. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $8.32bn and net income of $1.56bn. At that date it held total assets of $14.29bn and shareholders' equity of $5.05bn.
Solventum Corporation ("Solventum," "we," "our," "us," or the "Company"), is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs. We constantly seek to enable the improvement of standards of care and move healthcare forward with innovation powered by insights, clinical intelligence, technology, and manufacturing expertise. Our 70+ year history of discovering and innovating advanced solutions has helped us solve our customers’ toughest challenges.
Our solutions are relied on every day within the global healthcare industry to deliver higher-quality patient care, more efficient processes and workflows, and improved standards of safety and accuracy. Additionally, our products and services are present along a patient’s journey through prevention, diagnosis, treatment, and recovery.
Our business possesses strong customer relationships, a broad, wide-ranging, and well-known portfolio of brands, differentiated technology, and manufacturing expertise. We serve a diverse customer base, ranging from multidisciplinary hospitals to local clinics/practices. Our long-tenured and collaborative customer relationships globally give us unique insights into their needs and preferences. These insights inform our innovation processes, drive stronger customer retention, and create multiple avenues for further customer engagement.
Quoted from its 10-K, filed 27 Feb 2026. Read the filing on SEC.gov ↗
Latest on Solventum
Our reporting
Next results
Due on 25 Feb 2027. Analysts expect earnings of 1.77 a share.
Other N/A listings
Scenario calculator
Try your own numbers. This is arithmetic, not a forecast.
Gain or loss
Return
Leaves out fees, taxes and financing.
Frequently asked questions
What is Solventum's ticker?
Solventum trades as SOLV on its US listing, under ISIN US83444M1018.
What was Solventum's last closing price?
88.65 on 16 Nov 2026. The figure is in USD and is never converted.
When does Solventum next report results?
Results are expected on 5 Nov 2026, according to our data supplier.
Sources and methodology
- Chart
- TradingView
- Close and company data
- SEC filings and our data supplier
- News
- Our reporting
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.